Kai-Hsiung Chang

Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis

Cheng-Fan Lee, Ming-Shyue Lee, Hsiang-Po Huang, 2022, Oncogene.

Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer

C. Magi-Galluzzi, E. Klein, Jorge A. Garcia, 2017, eLife.

Abiraterone Inhibits 3β-Hydroxysteroid Dehydrogenase: A Rationale for Increasing Drug Exposure in Castration-Resistant Prostate Cancer

R. Auchus, N. Sharifi, Kristen Evaul, 2012, Clinical Cancer Research.

Prostate cancer—from steroid transformations to clinical translation

N. Sharifi, Kai-Hsiung Chang, 2012, Nature Reviews Urology.

Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer

Rui Li, R. Auchus, N. Sharifi, 2011, Proceedings of the National Academy of Sciences.

Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor

Shu-Pin Huang, Chih-Pin Chuu, Chia-Yang Li, 2022, PloS one.

The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth

M. Gleave, L. Fazli, Guanghua Xiao, 2014, Oncotarget.

Integrated Analysis of Ferroptosis-Related Biomarker Signatures to Improve the Diagnosis and Prognosis Prediction of Ovarian Cancer

X. Yi, Lingjie Bao, Kai-Hsiung Chang, 2022, Frontiers in Cell and Developmental Biology.

A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer

P. Nelson, C. Roehrborn, R. Vessella, 2013, Cell.

HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study.

D. Tindall, C. Magi-Galluzzi, C. Reddy, 2016, The Lancet. Oncology.

A birth‐to‐death view of mRNA from the RNA recognition motif perspective

T. Kinzy, J. Hurley, A. Esposito, 2008, Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology.

Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences

N. Sharifi, Kai-Hsiung Chang, C. Ercole, 2014, British Journal of Cancer.

Abiraterone Inhibits 3β-Hydroxysteroid Dehydrogenase: A Rationale for Increasing Drug Exposure in Castration-Resistant Prostate Cancer

R. Auchus, N. Sharifi, Kristen Evaul, 2012, Clinical Cancer Research.